Literature DB >> 28751556

ARID1A mutation in blastic plasmacytoid dendritic cell neoplasm.

Lei Wang1,2,3, Min Yang1,2,3, Xiang Zhang1,2,3, Chunmei Yang1,2,3, Xin Huang2,3, Zhaoming Wang4, Jie Jin5,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28751556      PMCID： PMC5664412          DOI： 10.3324/haematol.2017.172742

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia.

Authors:  Meng Li; Roxane Collins; Yuchen Jiao; Peter Ouillette; Dale Bixby; Harry Erba; Bert Vogelstein; Kenneth W Kinzler; Nickolas Papadopoulos; Sami N Malek
Journal:  Blood       Date:  2011-10-11       Impact factor: 22.113

Review 2.  SWI/SNF nucleosome remodellers and cancer.

Authors:  Boris G Wilson; Charles W M Roberts
Journal:  Nat Rev Cancer       Date:  2011-06-09       Impact factor: 60.716

3.  Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.

Authors:  J Menezes; F Acquadro; M Wiseman; G Gómez-López; R N Salgado; J G Talavera-Casañas; I Buño; J V Cervera; S Montes-Moreno; J M Hernández-Rivas; R Ayala; M J Calasanz; M J Larrayoz; L F Brichs; M Gonzalez-Vicent; D G Pisano; M A Piris; S Álvarez; J C Cigudosa
Journal:  Leukemia       Date:  2013-09-27       Impact factor: 11.528

4.  CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique.

Authors:  Dominique Leroux; Francine Mugneret; Mary Callanan; Isabelle Radford-Weiss; Nicole Dastugue; Jean Feuillard; Franseza Le Mée; Ghislaine Plessis; Pascaline Talmant; Nathalie Gachard; Françoise Uettwiller; Marie-Pierre Pages; Marie-Joëlle Mozziconacci; Virginie Eclache; Catherine Sibille; Hervé Avet-Loiseau; Marina Lafage-Pochitaloff
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

5.  High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients.

Authors:  Jeffrey W Tyner; Heidi Erickson; Michael W N Deininger; Stephanie G Willis; Christopher A Eide; Ross L Levine; Michael C Heinrich; Norbert Gattermann; D Gary Gilliland; Brian J Druker; Marc M Loriaux
Journal:  Blood       Date:  2008-12-15       Impact factor: 22.113

6.  BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.

Authors:  Frederik Damm; Virginie Chesnais; Yasunobu Nagata; Kenichi Yoshida; Laurianne Scourzic; Yusuke Okuno; Raphael Itzykson; Masashi Sanada; Yuichi Shiraishi; Véronique Gelsi-Boyer; Aline Renneville; Satoru Miyano; Hiraku Mori; Lee-Yung Shih; Sophie Park; François Dreyfus; Agnes Guerci-Bresler; Eric Solary; Christian Rose; Stéphane Cheze; Thomas Prébet; Norbert Vey; Marion Legentil; Yannis Duffourd; Stéphane de Botton; Claude Preudhomme; Daniel Birnbaum; Olivier A Bernard; Seishi Ogawa; Michaela Fontenay; Olivier Kosmider
Journal:  Blood       Date:  2013-09-18       Impact factor: 22.113

Review 7.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

Review 8.  Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches.

Authors:  Livio Pagano; Caterina G Valentini; Sara Grammatico; Alessandro Pulsoni
Journal:  Br J Haematol       Date:  2016-06-05       Impact factor: 6.998

9.  Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.

Authors:  Cigall Kadoch; Diana C Hargreaves; Courtney Hodges; Laura Elias; Lena Ho; Jeff Ranish; Gerald R Crabtree
Journal:  Nat Genet       Date:  2013-05-05       Impact factor: 38.330

10.  ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A.

Authors:  Chris T Williamson; Rowan Miller; Helen N Pemberton; Samuel E Jones; James Campbell; Asha Konde; Nicholas Badham; Rumana Rafiq; Rachel Brough; Aditi Gulati; Colm J Ryan; Jeff Francis; Peter B Vermulen; Andrew R Reynolds; Philip M Reaper; John R Pollard; Alan Ashworth; Christopher J Lord
Journal:  Nat Commun       Date:  2016-12-13       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.